Riskpilot← Back to searchSign inGet full accessAmbiCare AB
ABBankruptOrg 5593194375Manufacture of other plastic products · NACE 2226Est. 20210 employees
Revenue 2023
SEK 96K
-56% vs 2022
EBITDA margin
-302.6%
+48% vs 2022
Equity ratio
23.2%
Financial strength
Net profit 2023
SEK -477K
+34% vs 2022
| Revenue | SEK 96K | -56% |
| EBITDA | SEK -291K | +48% |
| Net profit | SEK -477K | +34% |
| Total assets | SEK 1,5M | -16% |
| Equity | SEK 346K | -44% |
| Employees | 0 | — |
Legal name
AmbiCare AB
Org number
5593194375
Legal form
Aktiebolag
NACE code
2226 · Manufacture of other plastic products
Founded
26 maj 2021
Share capital
SEK 31 061
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolagets verksamhet består av utveckling, distribution och försäljning av hjälpmedel för visuell brusreducering, huvudsakligen avskärmande glasögon.
Address
Email
thorunn@ambicare.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenue | 60 | 219 | 96 |
| Staff expenses | — | −132 | −196 |
| EBITDA | −77 | −561 | −291 |
| Depreciation & amort. | −0 | −119 | −122 |
| EBIT | −77 | −680 | −412 |
| Net financials | — | −46 | −64 |
| Profit before tax | −77 | −726 | −477 |
| Tax | −0 | — | — |
| Net profit | −77 | −726 | −477 |
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Total assets | 1 042 | 1 783 | 1 493 |
| Equity | 348 | 623 | 346 |
| Long-term debt | 200 | 620 | 570 |
| Short-term debt | 494 | 540 | 577 |
| Total debt | 694 | 1 160 | 1 147 |
EBITDA margin
-302.6%
This company
15.8%
Market median
-2015% vs market
20212023
Equity ratio
23.2%
This company
38.2%
Market median
-39% vs market
20212023
Return on equity
-137.8%
This company
18.4%
Market median
-849% vs market
20212023
Net profit margin
-496.3%
This company
8.1%
Market median
-6227% vs market
20212023
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20212023
Debt / equity
3.32×
This company
0.62×
Market median
-435% vs market
20212023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-05-01 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MC Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
nFocus AB | Company | 80.0% | 80.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
nFocus AB
AmbiCare AB Board members of AmbiCare AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Charlotta Skoog | Deputy Chief Executive Officer | 0 companies |
| Thorunn Kristin Widö | Chairman | 0 companies |
| Stefan Andreas Skoog | Deputy Board Member | 0 companies |
| Karl Martin Widö | Deputy Board Member | 0 companies |